The ePharmacy report provides a detailed evaluation of the market, including the adoption of ePharmacy within both developing and established markets. In addition, this report covers market opportunities; providing strategic insights into the technologies and key drivers that are pushing the space forward, and the role of 15 leading ePharmacy vendors across the market. The research suite also contains a detailed dataset; providing forecasts for 60 countries across a number of different metrics, including the number of ePharmacy users, number of ePharmacy transactions, number of OTC (Over the Counter) and prescription transactions through ePharmacy and total ePharmacy revenue.
Key Takeaways & Strategic Recommendations: Analysis of key development opportunities within ePharmacies, accompanied by key strategic recommendations for stakeholders.
Benchmark Industry Forecasts: Includes forecasts for total number of ePharmacy users, total annual spend on ePharmacy, total fee revenue from ePharmacy, total transaction value from ePharmacy. Total number of transactions and revenue split by OTC and prescription medication. This data is split by our 8 key forecast regions and 60 countries:
North America:
Key Statistics
- 795mn - ePharmacy users in 2022
- 1bn - ePharmacy users in 2027
- 28% - 2022 to 2027 growth in ePharmacy users
- 2022-2027 - Forecast period
Key Features
Market Dynamics: A strategic analysis of the major drivers, challenges, and innovations shaping the adoption and development of ePharmacy technologies, including the following:- COVID-19 impact on the ePharmacy market
- Future strategic direction and market outlook for ePharmacy
- Key issues ePharmacy vendors must be aware of surrounding legislation and data sharing
Key Takeaways & Strategic Recommendations: Analysis of key development opportunities within ePharmacies, accompanied by key strategic recommendations for stakeholders.
Benchmark Industry Forecasts: Includes forecasts for total number of ePharmacy users, total annual spend on ePharmacy, total fee revenue from ePharmacy, total transaction value from ePharmacy. Total number of transactions and revenue split by OTC and prescription medication. This data is split by our 8 key forecast regions and 60 countries:
North America:
- Canada, US
- Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru, Uruguay
- Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, UK
- Croatia, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, Ukraine
- China, Hong Kong, Japan, South Korea
- Bangladesh, India, Nepal, Pakistan
- Australia, Indonesia, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam
- Algeria, Egypt, Israel, Kenya, Kuwait, Nigeria, Qatar, Saudi Arabia, South Africa, United Arab Emirates
- 1mg
- Amazon Pharmacy
- Apollo Pharmacy
- CVS Health
- DocMorris
- Express Scripts
- Giant Eagle Pharmacy
- Kroger
- Lloyds Pharmacy
- Netmeds
- Optum
- Rowlands Pharmacy
- Walgreens Boots Alliance
- Walmart
- Well Pharmacy
Research Deliverables
- Market Trends & Forecasts PDF Report - A comprehensive analysis of the current market landscape, alongside strategic recommendations and a walk-through of the forecasts.
- Interactive Forecast Excel - Full 5-year forecasts for every available market metric provided in Excel format, with interactive 'What If' and scenario tools.
- harvest Online Data Platform - Access the very latest data in our exclusive online data platform, harvest. All the data from Excel, with frequent updates and a more user-friendly interface.
Executive Summary
The number of ePharmacy users will reach 1 billion globally by 2027; increasing from 795 million in 2022, a growth of 28%. The research identified this increase as the culmination of surging adoption resulting from the COVID-19 pandemic, where consumers were unable to leave their homes and turned to receiving medication through ePharmacies. Growth will continue, as vendors focus on retaining and expanding their customer bases through refining the efficiency and simplicity that ePharmacy provides.Consumers will continue to utilise ePharmacies as they realise the benefits it provides them, including affordability of medication, and a wider range of choice compared to bricks-and-mortar pharmacies.
ePharmacy growth will be sustained by simplifying the online process. This can be achieved through more widespread acceptance of ePrescriptions; eliminating paper copies of their prescriptions.
ePharmacy services will continue to be predominantly utilised for OTC (Over-the-Counter) medication. OTC transactions will reach 8.9 billion globally in 2027, accounting for 64% of total global transaction value. This is compared to 5 billion prescription transactions globally in the same year. Prescription digitisation will lag behind due to consumer concerns around delivery accuracy, timing and missed deliveries. In order to allay these concerns and offset the abundance of illegitimate ePharmacies, real-time tracking and stronger regulations for ePharmacies should be priorities to secure future growth.
Companies Mentioned
- 1mg
- Amazon Pharmacy
- Apollo Pharmacy
- CVS Health
- DocMorris
- Express Scripts
- Giant Eagle Pharmacy
- Kroger
- Lloyds Pharmacy
- Netmeds
- Optum
- Rowlands Pharmacy
- Walgreens Boots Alliance
- Walmart
- Well Pharmacy
